Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00229
|
|||||
| Drug Name |
Ochratoxin A
|
|||||
| Synonyms |
(-)-N-((5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenylalanine; 303-47-9; 3R14S-OCHRATOXIN A; Antibiotic 9663; C20H18ClNO6; CHEBI:7719; N-(((3R)-5-Chloro-8-hydroxy-3-methyl-1-oxo-7-isochromanyl)carbonyl)-3-phenyl-L-alanine; NCI-C56586; NSC 201422; OTA; Ochratoxin A; Ochratoxin A, aspergillus ochraceus; Ochratoxin A-BSA conjugate from Aspergillus ochraceus; Phenylalanine - ochratoxin A; RWQKHEORZBHNRI-BMIGLBTASA-N; UNII-1779SX6LUY
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C20H18ClNO6
|
|||||
| Canonical SMILES |
CC1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)NC(CC3=CC=CC=C3)C(=O)O)Cl
|
|||||
| InChI |
InChI=1S/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1
|
|||||
| InChIKey |
RWQKHEORZBHNRI-BMIGLBTASA-N
|
|||||
| CAS Number |
CAS 303-47-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 403.8 | Topological Polar Surface Area | 113 | ||
| Heavy Atom Count | 28 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
4.7
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10299065
, 103724058
, 104627857
, 11120179
, 11120667
, 11121155
, 11147262
, 118696750
, 12141
, 124892384
, 134350815
, 135697901
, 137023330
, 143857343
, 162222995
, 16490396
, 170481060
, 178101387
, 184581817
, 198986655
, 224840091
, 226405585
, 241182305
, 24712295
, 24860804
, 24870560
, 24897954
, 24897972
, 26755747
, 26755748
, 3139649
, 36886052
, 47662027
, 47736217
, 48334225
, 48334226
, 48414248
, 48423859
, 49759540
, 49855309
, 50111288
, 53790274
, 56310922
, 56312193
, 56313137
, 56313924
, 57649028
, 74764013
, 85844004
, 88782767
|
|||||
| ChEBI ID |
CHEBI:7719
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | ABCA8 | Transporter Info | ATP-binding cassette sub-family A member 8 | Substrate | [1] | |
| OAT1 | Transporter Info | Organic anion transporter 1 | Substrate | [2] | ||
| OAT3 | Transporter Info | Organic anion transporter 3 | Substrate | [2] | ||
| OAT4 | Transporter Info | Organic anion transporter 4 | Substrate | [3] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | ABCA8 | Transporter Info | Km = 0.4 microM | Xenopus laevis oocytes-ABCA8 | [1] | |
| OAT1 | Transporter Info | Km = 0.42 microM | Proximal tubule (S2) cells-OAT1 | [2] | ||
| OAT3 | Transporter Info | Km = 0.75 microM | Proximal tubule (S2) cells-OAT3 | [2] | ||
| OAT4 | Transporter Info | Km = 22.9 microM | Proximal tubule (S2) cells-OAT4 | [3] | ||
| References | ||||||
| 1 | Functional analysis of ABCA8, a new drug transporter. Biochem Biophys Res Commun. 2002 Oct 18;298(1):41-5. | |||||
| 2 | Characterization of ochratoxin A transport by human organic anion transporters. Life Sci. 2001 Sep 21;69(18):2123-35. | |||||
| 3 | Role of human organic anion transporter 4 in the transport of ochratoxin A. Biochim Biophys Acta. 2002 Jun 12;1590(1-3):64-75. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.